MREO

Mereo BioPharma
MREO

Overview Fund Activity

71 hedge funds and large institutions have $283M invested in Mereo BioPharma in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+5
Holders Change %
+7.58%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
23
Reduced
16
Closed
10
Calls
$547K
Puts
$447K
Net Calls
+$100K
Net Calls Change
-$237K

Top Buyers

1
RCMNY
1
Rubric Capital Management (New York)
New York
$17.9M
2
SCM
2
Suvretta Capital Management
New York
$27.4M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$32M
4
TLP
4
Tri Locum Partners
New York
$3.97M
5
Holocene Advisors
5
Holocene Advisors
New York
$6.18M

Top Sellers

1
O
1
OrbiMed
New York
$54.7M
2
PA
2
Perceptive Advisors
New York
$5.38M
3
BBA
3
Baker Bros. Advisors
New York
$7.8M
4
SFM
4
Sphera Funds Management
Israel
$0
5
Millennium Management
5
Millennium Management
New York
$5.28M
Name Holding Trade Value Shares
Change 		Shares
Change %
Cetera Investment Advisers
76
Cetera Investment Advisers
Illinois
– -$48K -14,100 Closed
CCM
77
CAAS Capital Management
New York
– -$34K -10,000 Closed
TCWM
78
Total Clarity Wealth Management
Illinois
– -$7K -2,150 Closed
SPIA
79
Steward Partners Investment Advisory
New York
– -$6.74K -2,000 Closed
1 2 3
4